Cargando…

Secondary Abdominal Cocoon Syndrome Due To Chronic Beta-Blocker Use

Sclerosing encapsulating peritonitis (SEP), which is interchangeably used with the term ‘’abdominal cocoon syndrome’’, is a rare condition characterized by a thick fibrous membrane encasing portions of the intestinal wall leading to recurrent bowel obstructions. To date, literature describing the as...

Descripción completa

Detalles Bibliográficos
Autores principales: Asotibe, Jennifer C, Zargar, Pejman, Achebe, Ikechukwu, Mba, Benjamin, Kotwal, Vikram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571602/
https://www.ncbi.nlm.nih.gov/pubmed/33094050
http://dx.doi.org/10.7759/cureus.10509
_version_ 1783597200879648768
author Asotibe, Jennifer C
Zargar, Pejman
Achebe, Ikechukwu
Mba, Benjamin
Kotwal, Vikram
author_facet Asotibe, Jennifer C
Zargar, Pejman
Achebe, Ikechukwu
Mba, Benjamin
Kotwal, Vikram
author_sort Asotibe, Jennifer C
collection PubMed
description Sclerosing encapsulating peritonitis (SEP), which is interchangeably used with the term ‘’abdominal cocoon syndrome’’, is a rare condition characterized by a thick fibrous membrane encasing portions of the intestinal wall leading to recurrent bowel obstructions. To date, literature describing the association between this condition and chronic beta-blocker therapy is scarce. This report adds by detailing a rare presentation of SEP and highlights an understudied yet important association of SEP with chronic beta-blocker therapy.
format Online
Article
Text
id pubmed-7571602
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-75716022020-10-21 Secondary Abdominal Cocoon Syndrome Due To Chronic Beta-Blocker Use Asotibe, Jennifer C Zargar, Pejman Achebe, Ikechukwu Mba, Benjamin Kotwal, Vikram Cureus Gastroenterology Sclerosing encapsulating peritonitis (SEP), which is interchangeably used with the term ‘’abdominal cocoon syndrome’’, is a rare condition characterized by a thick fibrous membrane encasing portions of the intestinal wall leading to recurrent bowel obstructions. To date, literature describing the association between this condition and chronic beta-blocker therapy is scarce. This report adds by detailing a rare presentation of SEP and highlights an understudied yet important association of SEP with chronic beta-blocker therapy. Cureus 2020-09-17 /pmc/articles/PMC7571602/ /pubmed/33094050 http://dx.doi.org/10.7759/cureus.10509 Text en Copyright © 2020, Asotibe et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Gastroenterology
Asotibe, Jennifer C
Zargar, Pejman
Achebe, Ikechukwu
Mba, Benjamin
Kotwal, Vikram
Secondary Abdominal Cocoon Syndrome Due To Chronic Beta-Blocker Use
title Secondary Abdominal Cocoon Syndrome Due To Chronic Beta-Blocker Use
title_full Secondary Abdominal Cocoon Syndrome Due To Chronic Beta-Blocker Use
title_fullStr Secondary Abdominal Cocoon Syndrome Due To Chronic Beta-Blocker Use
title_full_unstemmed Secondary Abdominal Cocoon Syndrome Due To Chronic Beta-Blocker Use
title_short Secondary Abdominal Cocoon Syndrome Due To Chronic Beta-Blocker Use
title_sort secondary abdominal cocoon syndrome due to chronic beta-blocker use
topic Gastroenterology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571602/
https://www.ncbi.nlm.nih.gov/pubmed/33094050
http://dx.doi.org/10.7759/cureus.10509
work_keys_str_mv AT asotibejenniferc secondaryabdominalcocoonsyndromeduetochronicbetablockeruse
AT zargarpejman secondaryabdominalcocoonsyndromeduetochronicbetablockeruse
AT achebeikechukwu secondaryabdominalcocoonsyndromeduetochronicbetablockeruse
AT mbabenjamin secondaryabdominalcocoonsyndromeduetochronicbetablockeruse
AT kotwalvikram secondaryabdominalcocoonsyndromeduetochronicbetablockeruse